home / stock / imlff / imlff news

IMLFF News and Press, InMed Pharmaceuticals Inc. From 01/21/20

Stock Information
Company Name: InMed Pharmaceuticals Inc.
Stock Symbol: IMLFF
Market: OTC
Menu
IMLFF IMLFF Quote IMLFF Short IMLFF News IMLFF Articles IMLFF Message Board
Get IMLFF Alerts

News, Short Squeeze, Breakout and More Instantly...
IMLFF - InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview

VANCOUVER , Jan. 21, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cann...
IMLFF - InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials

InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials Canada NewsWire VANCOUVER, Jan. 20, 2020 VANCOUVER , Jan. 20, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company de...

IMLFF - InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress

InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress Canada NewsWire VANCOUVER, Jan. 16, 2020 VANCOUVER , Jan. 16, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developi...

IMLFF - InMed Pharmaceuticals (IMLFF) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by InMed Pharmaceuticals Inc. in conjunction with this Read more ...

IMLFF - InMed Announces Election of Directors

VANCOUVER , Jan. 10, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today confirmed that at its annual ...

IMLFF - InMed Pharmaceuticals to Present at the Biotech Showcase Conference

VANCOUVER , Jan. 8, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that Eric A. Adams , ...

IMLFF - Global OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing

Global OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing Canada NewsWire NEW YORK, Dec. 9, 2019 Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentat...
IMLFF - InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa

VANCOUVER , Dec. 9, 2019 /PRNewswire/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced it has receiv...

IMLFF - Live Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th

NEW YORK , Dec. 2, 2019 /PRNewswire/ -- /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are i...

IMLFF - Live Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th

NEW YORK , Nov. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series.  Individual investors, institutional investors, advisors and analysts are invited to...
Previous 10 Next 10